Combining rosuvastatin with angiotensin-receptor blockers of different PPARγ activating capacity: effects on platelet indices associated with cardiovascular disease Christos Rizos, Evangelos Liberopoulos, Stavroula Tsiara, Moses Elisaf
Effects of monotherapy with high-dose rosuvastatin compared with the combination of low-dose rosuvastatin with fenofibrate or n-3 fatty acids on non-lipid serum parameters in patients with severe mixed dyslipidemia AP. Agouridis, TD. Filippatos, MS. Kostapanos, V. Tsimihodimos, DP. Mikhailidis, AD. Tselepis, MS. Elisaf